Our "War on Pain" Biotech Put You Up by Double Digits in Just Two Weeks

Insys Therapeutics - our "War on Pain" biotech play - has given us a profit of more than 10.7% since we recommended the stock a little less than two weeks ago. I hope you like profits, because that's just for starters. The U.S. Food and Drug Administration (FDA) last week approved the final "product label" for the company's new synthetic marijuana drug - which means Insys can bring this new therapy to market in August. Investors who specialize in drug stocks are always trying to pull profits from trades based on the three-step FDA "phalanx" that up-and-coming biotechs must navigate to finally get a new drug to market. But if you really want to cash in, commercialization is the "triggering event" that can make that happen. And that's exactly where Insys is right now. Let me give you a little bit of context here - before I explain exactly what's going to happen next... Tags: biotechnology To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Our "War on Pain" Biotech Put You Up by Double Digits in Just Two Weeks appeared first on Money Morning - We Make Investing Profitable .